rs4242630

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006180.6(NTRK2):​c.2173-23576C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.728 in 152,158 control chromosomes in the GnomAD database, including 40,991 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.73 ( 40991 hom., cov: 33)

Consequence

NTRK2
NM_006180.6 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.866

Publications

0 publications found
Variant links:
Genes affected
NTRK2 (HGNC:8032): (neurotrophic receptor tyrosine kinase 2) This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation. Mutations in this gene have been associated with obesity and mood disorders. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
NTRK2 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 58
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • obesity, hyperphagia, and developmental delay
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_006180.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.809 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006180.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NTRK2
NM_006180.6
MANE Select
c.2173-23576C>T
intron
N/ANP_006171.2
NTRK2
NM_001018064.3
c.2125-23576C>T
intron
N/ANP_001018074.1Q548C2
NTRK2
NM_001369532.1
c.2125-23576C>T
intron
N/ANP_001356461.1Q16620-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NTRK2
ENST00000277120.8
TSL:1 MANE Select
c.2173-23576C>T
intron
N/AENSP00000277120.3Q16620-4
NTRK2
ENST00000323115.11
TSL:1
c.2089-23576C>T
intron
N/AENSP00000314586.5A0A8J8YUT9
NTRK2
ENST00000686324.1
c.2173-23576C>T
intron
N/AENSP00000510134.1Q16620-4

Frequencies

GnomAD3 genomes
AF:
0.728
AC:
110705
AN:
152040
Hom.:
40954
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.816
Gnomad AMI
AF:
0.760
Gnomad AMR
AF:
0.744
Gnomad ASJ
AF:
0.744
Gnomad EAS
AF:
0.381
Gnomad SAS
AF:
0.702
Gnomad FIN
AF:
0.587
Gnomad MID
AF:
0.804
Gnomad NFE
AF:
0.719
Gnomad OTH
AF:
0.739
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.728
AC:
110800
AN:
152158
Hom.:
40991
Cov.:
33
AF XY:
0.718
AC XY:
53427
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.816
AC:
33878
AN:
41516
American (AMR)
AF:
0.745
AC:
11384
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.744
AC:
2578
AN:
3464
East Asian (EAS)
AF:
0.381
AC:
1968
AN:
5172
South Asian (SAS)
AF:
0.703
AC:
3385
AN:
4818
European-Finnish (FIN)
AF:
0.587
AC:
6212
AN:
10578
Middle Eastern (MID)
AF:
0.796
AC:
234
AN:
294
European-Non Finnish (NFE)
AF:
0.719
AC:
48908
AN:
68002
Other (OTH)
AF:
0.739
AC:
1560
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1522
3044
4567
6089
7611
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
828
1656
2484
3312
4140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.729
Hom.:
5244
Bravo
AF:
0.739
Asia WGS
AF:
0.629
AC:
2187
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.32
DANN
Benign
0.27
PhyloP100
-0.87
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4242630;
hg19: chr9-87611545;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.